{
  "ptid_time": "153_S_4125_2011-10-25",
  "img_path": "/data/qiuhui/data/adni/images/153_S_4125/2011-10-25/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 28,576 mm³, 1.8% above the reference mean. With a Z-score of 0.04 (51.7th percentile), this represents normal volume ; hippocampal volume measures 6,948 mm³, 2.3% below the reference mean. With a Z-score of -0.21 (41.5th percentile), this represents normal volume ; whole brain volume measures 929,173 mm³, 4.7% below the reference mean. With a Z-score of -0.59 (27.8th percentile), this represents normal volume ; entorhinal cortex volume measures 3,412 mm³, 7.1% below the reference mean. With a Z-score of -0.44 (33.1th percentile), this represents normal volume ; fusiform gyrus volume measures 19,235 mm³, 13.1% above the reference mean. With a Z-score of 1.19 (88.3th percentile), this represents mild enlargement; middle temporal gyrus volume measures 19,776 mm³, 3.2% above the reference mean. With a Z-score of 0.27 (60.8th percentile), this represents normal volume . ",
  "text_data": "Age is 75.8 years. Gender is Female. Education: 12 years. Handedness: Right. Race: White. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Musculoskeletal; Gastrointestinal; Major Surgical Procedures. MMSE: 30.0. MoCA: 24.0. Logical Memory: 11.0. Laboratory findings: MCH: 34.00 (significant elevated); Monocytes: 10.30 (significant elevated); RBC: 3.60 (significant reduced); Creatine Kinase: 201.00 (significant elevated); Triglycerides (GPO): 242.00 (significant elevated). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 0.95 SUVR (mild reduced); Amyloid beta: 1685.00 pg/mL (moderate elevated); Total tau: 159.10 pg/mL (mild reduced); Phosphorylated tau: 14.88 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The brain volume measurements are largely within normal ranges, with only mild deviations (e.g., fusiform gyrus enlargement). The MMSE is normal (30/30), but the MoCA (24/30) suggests mild cognitive impairment (MCI). Biomarkers show moderately elevated Aβ (consistent with amyloid pathology) but normal-to-mildly reduced tau and AV45, which is atypical for Alzheimer’s.  \n**Diagnosis:** **MCI** (likely amnestic given MoCA score, but not strongly supported by hippocampal volume).  \n**Confidence:** **Medium** (biomarkers are mixed, and structural changes are minimal despite cognitive findings).",
  "timestamp": "2025-07-26T17:10:46.325401"
}